KEEP is designed to meet the unique challenges faced by schizophrenia patients, helping manage their daily dosing regimens seamlessly integrating into patients’ lives, improving adherence and reducing treatment burdens. In tandem, KEEP supports new product launches for pharma, unlocking deep insights into the patient and supporter experience.
passively capture dosing events
real time insights for manufacturers and health system partners
Key Challenge:
Early adoption and long term adherence.
KEEP’s Solution:
KEEP passive medication tracking and personalized experience supports critical initiation and long-term medication ritual creation. Identify leading indicators to therapy discontinuation, and create salvage strategies.
Key Challenge:
Enabling extended support while maintaining independence.
KEEP’s Solution:
Coordinate personalized treatment plans for the individual, while safeguarding outcomes by involving patient supporters through remote patient monitoring.
Key Challenge:
Establish trust with prescribers and gain new Rx.
KEEP’s Solution:
Understand the new mechanism of action and patient experience in the real-world. Reduce hesitancy from prescribers by utilizing real world data to demonstrate effectiveness compared to tradtitional antipsychotics.
While real-world data captures how patients take their medication, KEEP goes beyond that with Real World Experience (RWE-X). RWE-X captures the true, human experience of living with schizophrenia, giving pharma companies insights into how patients navigate their day-to-day lives with their treatment. This deeper understanding allows healthcare providers to offer more personalized and timely support, ultimately improving outcomes and patient satisfaction.
Pilot Phase
In the initial pilot phase, KEEP will be deployed to a select group of patients on Cobenfy to demonstrate its impact on adherence and patient engagement.
Evaluation & Scaling
Following the pilot, we’ll assess the results and work with your team to fine-tune KEEP’s features to ensure maximum benefit for all patients on Cobenfy.
Full-Scale Rollout
Once the pilot is complete, KEEP will be rolled out across all Cobenfy patients, helping you deliver improved adherence and engagement at scale.
